Health Canada Approved the Use of Low Dose Pfizer Vaccine for Children

The new lower dose pediatric formulation of the Comirnaty COVID-19 vaccine by Pfizer-BioNTech has been authorized by Health Canada as Canada's first COVID-19 vaccine for use in children aged 5 to 11 years. Source: https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/pfizer-biontech-10-mcg-children-5-11-years-age/summary/summary.pdf Produced by Saveta Cartwright

© 2020 CJSR 88.5 FM